Member Login Area
Member Icon Login
Member Login
Member Icon Close

Assay List ( Method Library)

  • Recently Validated Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    1 Amphotericin B (Liposomal ) Antifungal Human Plasma K3EDTA LC/MS/MS LCMS-8050 100 40000
    2 Artimether + Dihydroartemisinin Antimalarial Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    0.50
    300
    300
    3 Flibanserin HypoactiveSsexual Desire Disorder (HSDD) Human Plasma K3EDTA LC/MS/MS API 4000 4.00 1400
    4 Ipratropium Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.60 pg/mL 180 pg/mL
    5 Nitroglycerin + 1,2-Dinitroglycerin + 1,3-Dinitroglycerin Vasodilator Human Plasma K3EDTA LC/MS/MS API 5500 0.010
    0.020
    0.010
    5.00
    10.00
    5.00
    6 Pazopanib Anticancer Human Plasma K3EDTA LC/MS/MS API 3200 300 15000
    7 Salmeterol Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.001 0.50
    8 Secnidazole Antiamoebic Human Plasma K3EDTA LC/MS/MS API 3000 200 80000
    9 Spironolactone Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE0 0.50 250
    10 Azilsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 30.0 15000
    11 Chlorpromazine + 7-Hydroxy Chlorpromazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020
    0.020
    20.0
    20.0
    12 Dapagliflozine Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500
    13 Dexamethasone Corticosteroid Human Plasma K3EDTA LC/MS/MS API 4000 0.50 150
    14 Esomeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 2.00 800
    15 Hydrocortisone (Total) Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500
    16 Levothyroxine + Liothyronine Thyroid Hormone Defficiency Human Plasma NA LC/MS/MS LCMS-8050 20.0
    0.30
    1000
    15.0
    17 Lumafantrine Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 50.0 30000
    18 Olaparib Anticancer Human Plasma K3EDTA LC/MS/MS API 3200 50.0 20000
    19 Pirfenidone Idiopathic pulmonary fibrosis (IPF) Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 30000
    20 Riluzole Amyotrophic lateral sclerosis Human Plasma K3EDTA LC/MS/MS API 4000 1.00 500
  • Recently Validated Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    21 Bilastine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 600
    22 Brexpiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 150
    23 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 8.00
    24 Bupivacaine Local Anesthetic Human Plasma K3EDTA LC/MS/MS Premiere XE 5.00 2500
    25 Darunavir Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS Premiere XE 50.0 20000
    26 Dexamethasone Corticosteroid Human Plasma K3EDTA LC/MS/MS API 4000 0.25 100
    27 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 40.0 40000
    28 Enzalutamide Metastatic castration-resistant prostate cancer (CRPC) Human Plasma K3EDTA LC/MS/MS API 2000 20.0 10000
    29 Griseofulvinx Antifungal Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000
    30 Leuprolide Prostate cancer, Breast cancer Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 200
    31 Quinidine Antianginal Human Plasma K3EDTA LC/MS/MS LCMS-8050 4.0 4000
    32 Ranolazine Antianginal Human Plasma K3EDTA LC/MS/MS Premiere XE 10.0 6000
    33 Sacubitril + Valsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 15.0
    25.0
    6000
    10000
    34 VIN-NCE-60PL Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2500
    35 Abiraterone Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 500
    36 Acyclovir Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
    37 Amphotericin B (Free) Antifungal Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 2500
    38 Cefuroxime Antibacteria Human Plasma K3EDTA LC/MS/MS API 3200 API 3200 12000
  • Recently Validated Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    40 Chlorpromazine + 7-Hydroxy Chlorpromazine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    0.10
    250
    100
    41 Fexofenadine Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 4.00 2000
    42 Midazolam + 1-Hydroxy Midazolam Anxiolytic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.30
    0.10
    60.0
    20.0
    43 Octreotide Growth hormone producing tumors Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.050 15.0
    45 Pazopanib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 80000
    46 Pyrimethamine Antibacterial, Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 2.00 1000
    47 R-Ketoprofen + S-Ketoprofen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 25.0
    25.0
    15000
    15000
    48 Roflumilast Severe COPD associated with chronic bronchitis Human Plasma K3EDTA LC/MS/MS API 4000 0.100 20.0
    49 Simvastatin + Simvastatin Hydroxy Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.20
    0.10
    200
    100
    50 Atorvastatin + 2- Hydroxy Atorvastatin + 4- Hydroxy Atorvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020
    0.020
    0.010
    20.0
    20.0
    10.0
    51 Lamivudine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 20.0 6000
    52 Bisoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 150
    53 Dilclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 4000
    54 Estrone (Total) Oestrogen Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 50.0
    55 Ethosuximide Antiepileptic Human Plasma K3EDTA LC/MS/MS API 4000 800 200000
    56 R-Lercanidipine + S-Lercanidipine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025
    0.025
    20.0
    20.0
    57 Levothyroxine + Liothyronine Thyroid Hormone Defficiency Human Serum NA LC/MS/MS LCMS-8050 20.0
    0.30
    800
    12.0
    58 Nifedipine Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.25 100
    59 Nifedipine Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 250
    60 Venetoclax Chronic lymphocytic leukemia Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 2000
  • Recently Validated Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    61 Asenapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 20.0
    62 Clonidine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.003 1.50
    63 Deferasirox Iron Chelator Human Plasma K3EDTA LC/MS/MS LCMS-8050 100 60000
    64 Dexamethasone Corticosteroid Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 600
    65 Doxorubicin (Free ) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.0 2000
    66 Doxorubicin (Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 150 60000
    67 Irbesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 7500
    68 Lisinopril Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00 700
    69 Phenytoin Antiepileptic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 5000
    70 Spironolactone Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 250
    71 Sulfadoxine Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 1000 400000
    72 Atazanavir Antiviral Human Plasma K3EDTA LC/MS/MS API 3200 30.0 15000
    73 Bortezomib Anticancer Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0
    74 Droxidopa Parkinson's disease Human Plasma K3EDTA LC/MS/MS API 4000 10.0 6000
    75 Montelukast Lukotriene receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 1.00 400
    76 1,3,5-Trimethoxy Benzene Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.25 70.0
    77 Amisulpride Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
    78 Chlorzoxazone Muscle relaxant Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 20000
    79 Fluphenazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.003 2.10
    80 Paroxetine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.040 24.0
  • Recently Validated Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    81 Primidone Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 10.0 3000
    82 Tizoxanide Antiparasitic Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 25000
    83 Tiotropium Anticholinergic Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.20 pg/mL 100 pg/mL
    84 Vareniciline Nicotine Addiction Human Plasma K3EDTA LC/MS/MS API 5500 0.10 20.0
    85 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 8000
    86 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 15000
    87 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.10 50.0
    88 Sorafenib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 20.0 8000
    89 VIN-NCE-58PL NCE Human Plasma K2EDTA LC/MS/MS LCMS-8060 1.00 10000
    90 Aminocaproic acid Bleeding Disorders Human Plasma K3EDTA LC/MS/MS API 3200 500 100000
    91 Amitryptilyne +
    Nortryptilyne
    Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20
    0.050
    80.0
    20.0
    92 Brexpiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 60.0
    93 Cephalexin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 50.0 25000
    94 Chlorthalidone +
    Telmisartan
    Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00
    2.00
    250
    500
    95 Clomipramine +
    Desmethylclomipramine
    Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10
    0.050
    6.0
    30.0
    96 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 10.0
    97 Phloroglucinol Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2500
    98 R-Praziquantel +
    S-Praziquantel
    Anthelmintic Human Plasma K3EDTA LC/MS/MS API 4000 2.00
    2.00
    2000
    2000
    99 Tapentadol Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 200
    100 Telmisartan Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 500
    101 Temozolomide Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 20000
    102 Amlodipine +
    Valsartan
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    40.0
    12.0
    4800
  • Recently Validated Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    103 Dihydroartemisinin Anitmalerial Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
    104 Glimepiride Anitmalerial Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800
    105 Loperamide +
    N-Desmethyl Loperamide
    Antidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500 0.010
    0.010
    4.00
    4.00
    106 Methenamine Urinary Tract Infection Human Plasma K3EDTA LC/MS/MS API 3200 0.050 20.0
    107 Sulphamethoxazole +
    Antibacterial
    Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    0.025
    100
    5.00
    108 Zonisamide Antiepileptic Human Serum NA LC/MS/MS API 3200 10.0 3000
    109 VIN-NCE-040PL NCE Human Plasma K2EDTA LC/MS/MS LCMS-8050 1.00 1000
    110 VIN-NCE-045PL NCE Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.50 2000
  • Premium Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    1 Acitretin +
    13 - Cis Acitretin
    Psoriasis Human Plasma Na Heparin LC/MS/MS API 4000 2.00 500
    2 Aspirin +
    Salicylic acid (Sensitive)
    Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 2.00
    150
    1200
    10000
    3 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin+
    Glimpride+
    Glimpride M1 Metabolite
    Antihyperlipidemic



    Antidiabetic
    Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    0.10
    0.05
    0.50
    0.50
    40
    40
    20
    200
    200
    4 5-Azacitidine Antineoplastic Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 2500
    5 Bupropion +
    Hydroxy Bupropion+
    Erythro Bupropion +
    Threo Bupropion
    Antidepressant and Smoking
    cessation
    Human Plasma Sodium Heparin LC/MS/MS Premier XE 3.00
    10.0
    3.00
    5.00
    900
    3000
    900
    1500
    6 Bupropion +
    Hydroxy Bupropion+
    Erythro Bupropion +
    Threo Bupropion
    Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 1.00
    3.0
    0.80
    2.50
    300
    900
    240
    750
    7 Disulfiram For Chronic Alcoholism Human Plasma Na Heparin LC/MS/MS API 3000 25.0 5000
    8 Doxorubicin Metabolite
    (Doxorubicinol)
    Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.25 20
    9 Doxorubicin(Free) Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 50.0 5000
    10 Doxorubicin(Liposomal) Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 250 50000
    11 Doxorubicin (Total) Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 250 50000
    12 Doxorubicin (Free) Antineoplastic Human Plasma K3EDTA LC/MS/MS API 5500 10 2000
    13 Doxorubicin (Liposomal) Antineoplastic Human Plasma K3EDTA LC/MS/MS API 5500 150 60000
    14 Ergocalciferol Vitamin D2 Human Plasma K3EDTA LC/MS/MS API 5500 0.10 100
    15 Estrone Unconjugated +
    Estradiol Unconjugated +
    Norethindrone
    Oestrogen
    Oestrogen
    Progestogen
    Human Plasma K3EDTA LC/MS/MS API 5500 0.003
    0.001
    0.100
    0.400
    0.133
    13.3
    16 Ethinyl Estradiol(Sensitive) +
    Levonorgestrel
    Oestrogen
    Progestogen
    Human Plasma Na Heparin LC/MS/MS API 5500 0.001
    0.100
    0.250
    25.0
    17 EEquilin Total +
    Δ8,9-dehydroestrone Total
    Oestrogen Human Plasma K3EDTA LC/MS/MS API 5500 0.050
    0.025
    8.00
    4.00
    18 EEquilin Total Oestrogen Human Plasma K3EDTA LC/MS/MS API 5500 0.050 15.0
    19 Estrone Uncojugated +
    Equilin Unconjugated +
    Δ 8,9 Dehydroestrone Unconjugated
    Oestrogen Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.0030
    0.0045
    0.0045
    0.400
    0.600
    0.600
    20 Fesoterodine +
    5-OH Methyl Tolterodine
    Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 4000 0.01
    0.02
    7.5
    15.0
  • Premium Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    21 Fingolimod +
    Fingolimod Phosphate
    Multiple sclerosis Human Blood K3EDTA LC/MS/MS API5500 0.04 / 0.04 5.00/ 5.00
    22 Formoterol Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.0004 0.20
    23 13-cis-Retinoic Acid+
    4-Keto 13-cis-Retinoic Acid
    Vitamin A Human Plasma K3EDTA LC/MS/MS Premier XE 5.00
    10.0
    1000
    2000
    24 2-Hydroxy Oleic Acid Synthetic derivative of Oleic Acid Human Plasma Na-Heparin LC/MS/MS API 4000 25.0 25000
    25 R-Ibuprofen+
    S-Ibuprofen
    NSAID Human Plasma K3EDTA LC/MS/MS API 4000 1000 32000
    26 R-Ibuprofen +
    S-Ibuprofen
    NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 200
    200
    70000
    70000
    27 Isoniazide +
    Rifampicin +
    25 -Desacetyl Rifampicin+
    Ethambutol +
    Pyrazinamide
    Antitubercular Human Plasma Na Heparin LC/MS/MS API 4000 60
    15
    25
    15
    200
    6000
    1500
    2500
    1500
    20000
    28 Lurasidone Metabolite 14283 Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 1000
    29 Metformin+
    Pioglitazone+
    Hydroxy Pioglitazone
    Antipsychotic Human Plasma K3EDTA LC/MS/MS API 2000 10.00 2400
    30 R-Metoprolol+
    S-Metoprolol
    Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 500
    31 S-Methyl N, N- Diethyl
    dithiocarbamate (Disulfiram
    Secondary Metabolite )
    For Chronic Alcoholism
    (Disulfiram)
    Human Plasma Na Heparin LC/MS/MS API 3000 5.00 1000
    32 RSSS -Nebivolol +
    SRRR-Nebivolol
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.020
    0.020
    6
    6
    33 Niacin +
    Nicotinuric Acid(Metabolite)
    Vitamin Human Plasma K3EDTA LC/MS/MS API 4000 5.00
    15.0
    1000
    3000
    34 Paclitaxel (Free, Unbound) Antineoplastic Human Plasma Na Heparin LC/MS/MS API 4000 1.00 1500
    35 Paclitaxel (Free) Antineoplastic Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000
    36 Penicillamine Chelating Agent Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 4000
    37 Phenindione Anticoagulant/Vitamin K
    antagonist
    Human Plasma K3EDTA LC/MS/MS API 4000 50.0 20000
    38 Prednisolone Corticosteroid Human Plasma K3EDTA LC/MS/MS API 3000 2.0 1000
    39 cis & trans-Phytonadione Vitamin K Human Plasma K3EDTA LC/MS/MS API 4000 0.100
    0.100
    150
    150
    40 R-(+) -trans -tranylcypromine +
    S-(-) -trans-tranylcypromine
    Antidepressant and Anxiolytic Human Plasma K3EDTA LC/MS/MS API 4000 0.100
    0.200
    40.0
    80.0
  • Premium Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    41 Trientine +
    N1 -Acetyl triethylenetetramine
    Chelating agent Human Plasma K3EDTA LC/MS/MS API 3000 6.00
    10.0
    1500
    2500
    42 Trientine +
    N1 -Acetyl triethylenetetramine +
    N1,N10 -Diacetyl triethylenetetramine
    Chelating agent plasma K3EDTA LC/MS/MS API3000 10.0
    10.0
    3.00
    2000
    2000
    600
    43 Nitroglycerin +
    1, 2-Dinitroglycerin +
    1, 3-Dinitroglycerin
    Vasodilator Human Plasma K3EDTA LC/MS/MS API 5500 0.020
    0.050
    0.050
    2.00
    5.00
    5.00
    44 Prpranolol Total +
    4-OH Propranolol Total
    Beta–adrenoceptor Blocking Agent Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 500
    45 Pyridostigmine Anticholinesterase Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150
    46 Rivastigmine(Sensitive) Alzheimer's & Parkinson's Disease Human Plasma K3EDTA LC/MS/MS Premier XE 0.05 20
  • Pharmacodynamic / Pharmacokinetic / Immunogenicity Determination (Validated Kit Method)
    Sr. No. Activity/Marker Purpose Matrix Anti-Coagulant Method Equipment LLOQ ULOQ
    1 Nitrate Marker For the Activity of Nitric oxide synthase and the production of Nitric oxide radicals Human Plasma K3EDTA Colourimetric Microplate
    Reader
    5 μM 35 μM
    2 Nitrate Marker For the Activity of Nitric oxide synthase and the production of Nitric oxide radicals Human Plasma K3EDTA Colourimetric Microplate
    Reader
    5 μM 35 μM
    3 Anti Xa LMWH therapy is monitored by the ratio of anti-factor Xa and Anti Factor IIa assay, The amount of residual factor Xa or Factor IIa is inversely proportional to the amount of heparin/LMWH in the plasma Human Plasma Na-Citrate Chromogenic Microplate
    Reader
    0.1 IU/mL 1 IU/mL
    4 Anti IIa LMWH therapy is monitored by the ratio of anti-factor Xa and Anti Factor IIa assay, The amount of residual factor Xa or Factor IIa is inversely proportional to the amount of heparin/LMWH in the plasma Human Plasma Na-Citrate Chromogenic Microplate
    Reader
    0.05 IU/mL 0.2 IU/mL
    5 TFPI Extrinsic Pathway- Tissue Factor Pathway Inhibitor, For Determination of heparin Presence. Human Plasma CTAD ELISA- Colorimetric Microplate
    Reader
    31.25 pg/mL 2.0 ng/mL
    6 C-Peptide NA Human Serum NA ELISA Microplate
    Reader
    28.89 pM 1850 pM
    7 G-CSF Febrile Neutropenia Human Serum NA ELISA Microplate
    Reader
    SYNERGY H1
    2.014 50.0
    8 Heparin Clotting Assay To determine the clotting time difference in presence of LMWH Human Plasma CTAD Clotting Assay Coagulation
    Analyzer
    0.15 IU/mL 1.0 IU/mL
    9 IgG Immunoglobulin- IgG, specific Heparin antibody qualitative detection for immunogenicity of Human Serum NA Qualitative-ELISA
    Method
    Microplate
    Reader
    NA NA
    10 IgA Immunoglobulin- IgA, specific Heparin antibody qualitative detection for immunogenicity of LMWH Human Serum NA Qualitative-ELISA
    Method
    Microplate
    Reader
    NA NA
    11 IgM Immunoglobulin- IgM, specific Heparin antibody qualitative detection for immunogenicity of LMWH Human Serum NA Qualitative-ELISA
    Method
    Microplate
    Reader
    NA NA
    12 IgGAM Immunoglobulin- IgG, IgM and IgA, specific Heparin antibodies qualitative detection for immunogenicity of LMWH Human Serum NA Qualitative-ELISA
    Method
    Microplate
    Reader
    NA NA
    13 Insulin Aspart Antidiabetic Human Serum NA ELISA Microplate
    Reader
    SYNERGY H1
    15.714 pM 500 pM
    14 A-H-PF4 Anti Heparin Platlate factor Human Serum CTAD ELISA- Colorimetric Microplate
    Reader
    NA NA
    15 Total Iron For Estimation of total Iron after Iron sucrose therepy Human Serum NA Colourimetric Microplate
    Reader
    500 ng/mL 60000 ng/mL
    16 Transferrin bound Iron(TBI) For Estimation of transferrin bound Iron after Iron sucrose therapy Human Serum NA Colourimetric Microplate
    Reader
    200 ng/mL 8000 ng/mL
  • Validated Methods for New Chemical Entities
    Sr. No. In-House ID Matrix Anti-Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    1 VIN-NCE-001 PL-1 Human Plasma Na Heparin LC/MS/MS API 4000 0.5 500
    2 VIN-NCE-001 UR-1 Human Urine NA LC/MS/MS API 4000 0.5 5000
    3 VIN-NCE-002 PL Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000
    4 VIN-NCE-003 PL Human Plasma Na Heparin LC/MS/MS API 4000 20.0 5000
    5 VIN-NCE-004 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.020 10.0
    6 VIN-NCE-005 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.50 100
    7 VIN-NCE-006 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 1000
    8 VIN-NCE-007 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000
    9 VIN-NCE-008 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.10 100
    10 VIN-NCE-008 UR Human Urine NA LC/MS/MS API 4000 1.00 1000
    11 VIN-NCE-009 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.10 100
    12 VIN-NCE-009 UR Human Urine NA LC/MS/MS API 4000 1.00 1000
    13 VIN-NCE-010 PL Human Plasma K3EDTA LC/MS/MS API 3000 5.00 5000
    14 VIN-NCE-011 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000
    15 VIN-NCE-012 PL Human Plasma Na Heparin LC/MS/MS API 3000 0.50 500
    16 VIN-NCE-014 PL Human Plasma Na Heparin LC/MS/MS Premier XE 25.0 1000
    17 VIN-NCE-013 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 500
    18 VIN-NCE-015 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 500
    19 VIN-NCE-016 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.10 100
    20 VIN-NCE-017 BL Human Blood Na Heparin LC/MS/MS Premier XE 0.50 100
  • Validated Methods for New Chemical Entities
    Sr. No. In-House ID Matrix Anti-Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    21 VIN-NCE-018 BL Human Plasma Na Heparin LC/MS/MS API 3000 3.0 1200
    22 VIN-NCE-019 PL Human Plasma EDTA LC/MS/MS API 2000 10.0 250
    23 VIN-NCE-020 PL Human Plasma Na Heparin LC/MS/MS API 2000 1.00 25.0
    24 VIN-NCE-021 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.030 100
    25 VIN-NCE-022 SK Human Skin Na Heparin LC/MS/MS API 3000 12.0 9000
    26 VIN-NCE-023 PL Human Plasma Na Heparin LC/MS/MS API 3000 3.00 2400
    27 VIN-NCE-024 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 1000
    28 VIN-NCE-025 UR Human Urine Na Heparin LC/MS/MS Premier XE 0.50 1000
    29 VIN-NCE-026 PL Human Blood EDTA LC/MS/MS API 3000 0.30 200
    30 VIN-NCE-027 PL Human Plasma EDTA LC/MS/MS API 4000 2.00 1000
    31 VIN-NCE-028 PL Human Plasma EDTA LC/MS/MS Premier XE 5.00 3000
    32 VIN-NCE-029 PL Human Plasma Na Heparin LC/MS/MS Premier XE 2.00 2500
    33 VIN-NCE-030 TI Colon tissue NA LC/MS/MS API 3000 12.0 9000
    34 VIN-NCE-022 CT Colon tissue NA LC/MS/MS API 3000 12.0 9000
    35 VIN-NCE-031 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.50 5000
    36 VIN-NCE-032 PL Human Plasma K3EDTA LC/MS/MS API 5500 0.50 50.0
    37 VIN-NCE-034 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.005 5.50
    38 VIN-NCE-038 UR Human Plasma NA LC/MS/MS API 3200 1.00 1000
    39 VIN-NCE-037 UR Human Urine NA LC/MS/MS API 3200 10.00 10000
    40 VIN-NCE-043 PL Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
  • Validated Methods for New Chemical Entities
    Sr. No. In-House ID Matrix Anti-Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    41 VIN-NCE-035 PL Human Plasma K3EDTA LC/MS/MS API 3000 5.00 5000
    42 VIN-NCE-041 PL Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 2000
    43 VIN-NCE-039PL Human Plasma K3EDTA LC/MS/MS LCMS-8060 1.00 1000
    44 VIN-NCE-037UR Human Urine NA LC/MS/MS API 3200 10.0 10000
    45 VIN-NCE-042PL Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020 10.0
    46 VIN-NCE-044PL (Drug + Metabolite) Human Plasma K3EDTA LC/MS/MS Premier XE 1.00
    1.00
    1000
    1000
  • Methods Under Development / Validation
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    1 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS 30.0 7500
    2 Alverine +
    4-Hydroxy Alverine
    Smooth muscle relaxant Human Plasma K3EDTA LC/MS/MS 0.01
    0.05
    3.00
    15.0
    3 Bendroflumethiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS 0.50 200
    4 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS 10.0 3000
    5 Cyclosporin Immunosuppressant Human Plasma K3EDTA LC/MS/MS 5.0 2000
    6 Emtricitabine +
    Tenofovir Alfenamide
    Antiviral Human Plasma K3EDTA LC/MS/MS 20.0
    2.00
    5000
    500
    7 Enalapril +
    Enalaprilat
    Antihypertensive Human Plasma K3EDTA LC/MS/MS 1.00
    0.50
    500
    250
    8 Ketotifen Antihistamine Human Plasma K3EDTA LC/MS/MS 0.002 1.00
    9 Ketorolac NSAID Human Plasma K3EDTA LC/MS/MS 10.0 2000
    10 Ladipasvir +
    Sofusbivir
    Antiviral Human Plasma K3EDTA LC/MS/MS 2.00
    3.00
    1000
    1500
    11 Miglustat Gaucher disease Human Plasma K3EDTA LC/MS/MS 15.0 3000
    12 Palbociclib Anticancer Human Plasma K3EDTA LC/MS/MS 0.50 200
    13 Pazopanib Antineoplastic Human Plasma K3EDTA LC/MS/MS 100.0 40000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    1 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.00 9000
    2 Abacavir +
    Lamivudine
    Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 24.0
    60.0
    6000
    15000
    3 Abiraterone Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 200
    4 Acetaminophen Analgesic Human Plasma Na Heparin LC/MS/MS API 3000 300.00 20000
    5 Acetazolamide Carbonic anhydrase inhibitor,diuretic Human Plasma K3EDTA LC/MS/MS API 2000 20.00 20000
    6 Acetazolamide (Sensitive) Carbonic anhydrase inhibitor,diuretic Human Plasma K3EDTA LC/MS/MS API 2000 10.00 5000
    7 Acetazolamide Carbonic anhydrase inhibitor,diuretic Human Plasma K3EDTA LC/MS/MS API 2000 30.00 18000
    8 Acitretin Psoriasis Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.20 300
    9 Acitretin+
    13 - Cis Acitretin
    Psoriasis Human Plasma K3EDTA LC/MS/MS API 4000 5.00 500
    10 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 10.0
    11 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 50.0
    12 Amlodipine +
    Valsartan
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.100
    100
    10.0
    10000
    13 Albendazole +
    Albendazole Sulfoxide
    Anthelmintic Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    4.00
    100
    2000
    14 Alfuzosin Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.40 80
    15 Aliskiren Renin inhibitor Human Plasma K3EDTA LC/MS/MS API 3000 0.30 30 0
    16 Alosetron 5-HT3 Antagonist Human Plasma K3EDTA LC/MS/MS API 4000 0.05 20
    17 Alprazolam Anxiolytic Human Plasma Na Heparin LC/MS/MS Premier XE 0.20 40
    18 Allopurinol Anti gout Human Plasma K3EDTA LC/MS/MS LCMS-8050 15.0 9000
    19 Amantadine Antiviral and an
    Antiparkinsonian drug
    Human Plasma K3EDTA LC/MS/MS API 2000 2.00 1000
    20 Amitriptyline+
    Nortriptyline
    Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.08
    120
    48.0
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    21 Amitriptyline+
    Nortriptyline
    Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.09
    120
    48.1
    22 Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 10.0
    23 Amlodipine +
    HCTZ +
    Olmesartan
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    1.00
    10.0
    15.0
    300
    3000
    24 Amlodipine +
    Olmesartan
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.040
    10.0
    12.0
    3000
    25 Amlodipine +
    Telmisartan
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    5.00
    10.0
    1000
    26 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 160 30000
    27 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 200 30000
    28 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 50.0 25000
    29 Anastrazole Antineoplastic Human Plasma K3EDTA LC/MS/MS API 3000 0.20 60
    30 Apixaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
    31 Apremilast Psoriatic Arthritis Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 800
    32 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 4000
    33 Aripriprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 400
    34 Aripiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 200
    35 Aripriprazole +
    Escitalopram
    Antipsychotic, Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.25
    0.10
    65.0
    24.0
    36 Armodafinil Wakefulness promoting agent Human Plasma K3EDTA LC/MS/MS API 3000 50 15000
    37 Artemether+
    Dihydroartimisnin
    Antimalarial Human Plasma Na Heparin LC/MS/MS API 4000 3.00 360
    38 Artesunate +
    Dihydroartemisinin
    Antimalarial Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.800
    0.800
    500
    500
    39 Asenapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.10 20
    40 Aspirin +
    Salicylic Acid
    Analgesic Human Plasma Na Heparin LC/MS/MS API 2000 2000.00 80000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    41 Aspirin +
    Metabolite Salicylic acid
    Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 4.0
    100
    2000
    7000
    42 Aspirin(Sensitive) Analgesic Human Plasma K3EDTA LC/MS/MS Premier XE 10.00 2000
    43 Atenolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 8.00 2200
    44 Atomoxetine Hyperactivity disorder (ADHD) Human Plasma EDTA LC/MS/MS API 4000 5.00 2000
    45 Atorvastatin Antihyperlipidemic Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.50 300
    46 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin
    Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 3000 0.25
    0.50
    0.50
    50
    100
    100
    47 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin
    Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    0.10
    0.05
    100
    100
    50
    48 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin
    Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.2
    0.2
    0.1
    200
    200
    100
    49 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin
    Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.1
    0.1
    0.05
    40
    40
    20
    50 Atovaquone Antiprotozoal Human Plasma K3EDTA LC/MS/MS API 3000 100.00 20000
    51 Axitinib Antineoplastic Human Plasma K3EDTA LC/MS/MS Premier XE 0.200 100
    52 Axitinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.075 100
    53 Azithromycin Antibiotics Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
    54 Azithromycin Antibiotic Human Plasma K3EDTA LC/MS/MS API3000 5.00 2000
    55 Barnidipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 0.02 10
    56 Bexarotene Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
    56 Bexarotene Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
    57 Bisoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100
    58 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 4.50
    59 Bortezomib Antineoplastic Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1400
    60 Bortezomib Antineoplastic Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    61 Bosentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 50.00 5000
    62 Bosentan(Sensitive ) Endothelin receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 20.00 5000
    63 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.015 4.50
    64 Budesonide Diuretic Human Plasma K3EDTA LC/MS/MS API 3200 1.00 200
    65 Bupropion +
    Hydroxy Bupropion
    Antidepressant Human Plasma K3EDTA LC/MS/MS API 3000 1.50 300
    66 Buspiron Anxiolytic Human Plasma K3EDTA LC/MS/MS API 3000 0.05 5.00
    67 Cabergoline Dopamine receptor agonist Human Plasma K3EDTA LC/MS/MS API 5500 0.0015 0.100
    68 Canagliflozin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 6000
    69 Canagliflozin +
    Metformin
    Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 5.00
    5.00
    3000
    3000
    70 Candesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 500
    71 Candesartan +
    Hydrochlorothiazide
    Antihypertensive
    Diuretic
    Human Plasma K3EDTA LC/MS/MS API 3000 2.0
    1.0
    1000
    500
    72 Capecitabine Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 10.00 10000
    73 Captopril Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 1000
    74 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 2000 20.00 5000
    75 Carbamazepine Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 20.00 10000
    76 Carbidopa+
    Levodopa
    Parkinson's disease Human Plasma K3EDTA LC/MS/MS Premier XE 2.00
    20.0
    400
    4000
    77 Carbidopa+
    Levodopa
    Parkinson's disease Human Plasma K3EDTA LC/MS/MS API 5500 0.25
    20.0
    150
    4000
    78 Carbidopa+
    4-Hydroxyphenyl Carvedilol
    Beta–blocker Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150
    79 Carglumic Acid Carbamoyl Phosphate
    Synthetase 1 activator
    Human Plasma K3EDTA LC/MS/MS API 4000 50.0 10000
    80 Cefaclor Antibacterial Human Plasma CPDA, EDTA HPLC HPLC-UV 500 50000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    81 Cefaclor Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 20000
    82 Cefadroxil Antibiotic Human Plasma CPDA, EDTA LC/MS/MS API 2000 300 60000
    83 Cefadroxil Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 40000
    84 Cefditoren Antibiotic Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 5000
    85 Cefixime Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 100 20000
    86 Cefixime Cephalosporin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 25.0 15000
    87 Cefixime Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 20000
    88 Cefpodoxime acid Antibacterial Human Plasma EDTA LC/MS/MS API 2000 20.0 3000
    89 Cefpodoxime acid Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 200 10000
    90 Cefpodoxime acid Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 150 30000
    91 Cefpodoxime acid Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 75.0 1500
    92 Celecoxib Sulfa non-steroidal antiinflammatory drug (NSAID) Human Plasma K3EDTA LC/MS/MS API 4000 20.0 5000
    93 Celecoxib Antibacterial Human Plasma EDTA HPLC HPLC-UV 200 120000
    94 Celecoxib Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 500 50000
    95 Cetirizine Non-sedative Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
    96 Chlorpheniramine +
    Phenylephrine
    Antihistamine
    Decongestant
    Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    0.05
    20.0
    10.0
    97 Chlorthalidone Diruretic Human Plasma K3EDTA LC/MS/MS LC 8040 20.0 8000
    98 Cinnargine Antihistamine Human Plasma EDTA LC/MS/MS Premier XE 5.00 750
    99 Ciprofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 10000
    100 Clarithromycin Antibacterial Human Plasma EDTA LC/MS/MS API 3000 50.0 10000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    101 Clarithromycin +
    14(R)-hydroxy-Clarithromycin
    Antibacterial Human Plasma EDTA LC/MS/MS API 3000 40.0
    15.0
    8000
    3000
    102 Clobazam +
    N-Desmethyl Clobazam
    AED Human Plasma K3EDTA LC/MS/MS Premier XE 5.00
    1.00
    1500
    300
    103 Clomipramine +
    Desmethyl Clomipramine
    Antidepressant Human Plasma K3EDTA LC/MS/MS API 3000 1.00
    1.00
    300
    300
    104 Clomipramine +
    Desmethyl Clomipramine
    Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20
    0.80
    50.0
    200
    105 Clonazepam AED Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 30.0
    106 Clonazepam AED Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.05 20.0
    107 Clonidine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.025 2.50
    108 Clopidogrel Anti–platelet Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.20 25.0
    109 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS API 4000 0.05 10.0
    110 Clopidogrel+
    Clopidogrel Carboxylic acid
    Anti–platelet Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    50.0
    10.0
    10000
    111 Clozapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 1000
    112 Dabigratan Thrombin Inhibitor Human Plasma Na-Citrate LC/MS/MS API 4000 1.00 300
    113 Dalfampridine Multiple sclerosis Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 100
    114 Dapsone Antileprotic Human Plasma K3EDTA LC/MS/MS API 4000 25.0 5000
    115 Dapsone +
    N-Acetyl Dapsone
    Antileprotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.045
    0.015
    18.0
    6.00
    116 S-Dapoxetine Selective serotonin reuptake inhibitor Human Plasma EDTA LC/MS/MS API 4000 1.00 1000
    117 Darifenacin Urinary incontinence. Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 5.00
    118 Darunavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 20000
    119 Dasatinib Tyrosine Kinase
    Inhibitor/Antineoplastic
    Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
    120 Deferasirox Iron Chelator Human Plasma K3EDTA LC/MS/MS API 2000 100 60000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    121 Deferiprone +
    Deferiprone Glucuronide
    Iron Chelator Human Plasma Na Heparin LC/MS/MS API 2000 250
    125
    40000
    20000
    122 Desipramine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.50 150
    123 Desipramine +
    2-Hydroxy Desipramine
    Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.5
    0.15
    150
    45
    124 Desloratadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0
    125 Desloratadine +
    3-Hydroxy Desloratidine
    Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 0.05 10.0
    126 Desloratadine +
    3-Hydroxy Desloratidine
    Antihistamine Human Plasma EDTA LC/MS/MS API 4000 0.05 10.0
    127 Desmopressin Synthetic replacement of vasopressin harmone Human Plasma K3EDTA LC/MS/MS APi5500 0.002 0.025
    128 Dexlansoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2500
    129 Dextromethorphan +
    Dextrorphan
    Cough Suppressant Human Plasma K3EDTA LC/MS/MS API 3000 0.10
    10.0
    20.0
    2000
    130 Dextromethorphan +
    Guanafenesin
    Cough Suppressant
    Expectorant
    Human Plasma K3EDTA LC/MS/MS API 3000 0.10
    25.0
    20.0
    5000
    131 Diacerein +
    Rhein
    Osteoarthritis Human Plasma K3EDTA LC/MS/MS LCMS-8050 15.0
    15.0
    6000
    6000
    132 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 25.0 4000
    133 Diclofenac +
    Esomeprazole
    Analgesic
    Proton pump inhibitor
    Human Plasma K3EDTA LC/MS/MS API 4000 8.00
    4.00
    4000
    2000
    134 Dicloxacillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 200 80000
    135 Dihydrotetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 200
    136 Diltiazem +
    N-Desmethyl Diltiazem +
    Desacetyl Diltiazem
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 1.5
    0.5
    0.5
    450
    150
    150
    137 Diltiazem +
    N-Desmethyl Diltiazem +
    Desacetyl Diltiazem
    Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 4.00
    1.00
    0.50
    1200
    300
    150
    138 Diphendydramine +
    Naproxen
    Sedative antihistamine NSAID Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    500
    150
    150000
    139 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 4500
    140 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 5000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    141 Disulfiram Metabolite 2 For Chronic Alcoholism
    (Disulfiram)
    Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 250
    142 Disulfiram Primary Metabolite NA (Inactive Metabolite of
    Disulfiram)
    Human Plasma K3EDTA HPLC-UV Shimadzu LC20 2.00 200
    143 Dofetilide Antiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000 0.010 5.00
    144 Donepezil Nootropic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200
    145 Donepezil
    Mementine
    Alzheimer Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    0.50
    200
    200
    146 Doxorubicin (Total) Antineoplastic Human Plasma K3EDTA LC/MS/MS API 3000 150 60000
    147 Doxycycline Antibacterial Human Plasma Na Heparin LC/MS/MS Premier XE 10.0 5000
    148 Doxycycline Antibacterial Human Plasma EDTA LC/MS/MS Premier XE 10.0 1500
    149 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API3000 10.0 7000
    150 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 10.0 7000
    151 Dronedarone+
    Desbutyl Dronedarone (Metabolite)
    Antiarrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50
    0.50
    300
    300
    152 Duloxetine (Sensitive) Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.40 150
    153 Duloxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100
    154 Dutastaride 5-alpha-reductase inhibitor Human Plasma K3EDTA LC/MS/MS API-4000 0.10 25.0
    155 Efavirenz Antiviral Human Plasma EDTA HPLC HPLC-UV 50.0 9000
    156 Efavirenz Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 30.0 6000
    157 Eletriptan Anti-Migraine Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 250
    158 Emtricitabin Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.0 3000
    159 Emtricitabine
    Tenofovir
    Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 20.0
    4.00
    4000
    800
    160 Enalapril +
    Enalaprilat
    Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 5.00
    2.00
    1000
    450
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    161 Enalapril +
    Metabolite
    Antiparkinsonian Human Plasma K3EDTA HPLC HPLC-UV 50.0 6000
    162 Enalapril +
    Metabolite (Sensitive)
    Antiparkinsonian Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 6000
    163 Entecavir Antiviral Human Plasma K3EDTA LC/MS/MS API 5500 0.040 20.0
    164 Enzalutamide Metastatic castration-resistant
    prostate cancer (CRPC)
    Human Plasma K3EDTA LC/MS/MS API 2000 10.0 10000
    165 Eplerenone Chronic Heart Failure Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 4000
    166 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 4000
    167 Eprosartan +
    Hydrochlorothiazide
    Antihypertensive
    Diuretic
    Human Plasma K3EDTA LC/MS/MS API 3000 30.0
    1.00
    7500
    500
    168 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 6000
    169 Erlotinib Antineoplastic Human Plasma K3EDTA LC/MS/MS Premier XE 12.5 2500
    170 Erlotinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 2500
    171 Erythromycin Antibacteria Human Plasma EDTA LC/MS/MS API 2000 20.0 2000
    172 Erythromycin Antibacteria Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 4000
    173 Escitalopram Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.30 200
    174 Escitalopram Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 50.0
    175 Escitalopram +
    S (+) Desmethylcitalopram
    Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    0.040
    50.0
    10.0
    176 Eslicarbazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 2000 100 30000
    177 Esomeprazole Proton pump inhibitor Human Plasma CPDA, EDTA LC/MS/MS API 2000 10.0 3500
    178 Esomeprazole (Sensitive) Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 2000 5.0 3500
    179 Esomeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 10.0 4000
    180 Esomeprazole +
    Naproxen
    Proton pump inhibitor NSAID Human Plasma K3EDTA LC/MS/MS API 4000 5.0
    500
    1500
    150000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    181 Esomeprazole +
    Naproxen
    Proton pump inhibitor NSAID Human Plasma K3EDTA LC/MS/MS API 4000 2.0
    500
    600
    150000
    182 Ethinyl Esterdiol +
    Levonorgetral
    Oestrogen Human Plasma Sodium Heparin LC/MS/MS API 5500 0.004
    0.10
    0.50
    20.0
    183 Etodolac Non-steroidal Antiinflammatory Human Plasma K3EDTA LC/MS/MS API 2000 500 80000
    184 Etodolac Nonsteroidal anti-inflammatory Human Plasma K3EDTA LC/MS/MS Premier XE 250 80000
    185 Etoposide Antineoplastic Human Plasma K3EDTA LC/MS/MS Premier XE 20.0 8000
    186 Etoposide COX-2 selective inhibitor Human Plasma K3EDTA LC/MS/MS API2000 10.0 5000
    187 Everolimus Antineoplastic Human Blood K3EDTA LC/MS/MS API3000 0.30 200
    188 Exemestane Aromatase inhibitor, Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 40
    189 Ezetimib +
    Ezetimibe-O-beta-glucuronide
    Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.10
    1.00
    25.0
    250
    190 Ezetimibe(Unconjugated) Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.13 20
    191 Ezetimib (Total) Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8040 1.00 200
    192 Ezetimibe+
    Ezetimibe Phenoxygluconoride
    Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    1.00
    15.0
    150
    193 Febuxostat Inhibitor of Xanthine Oxidase Human Plasma K3EDTA LC/MS/MS API 4000 50 10000
    194 Felodipine Antihypertensive Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0
    195 Felodipine Calcium channel blocker Human Plasma K3EDTA LC/MS/MS API 4000 0.10 10.0
    196 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 25.0 10000
    197 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 20000
    198 Fenoprofen Non-steroidal Antiinflammatory Human Plasma K3EDTA LC/MS/MS API 3000 250 100000
    199 Fesoterodine +
    5-Hydyroxy methyl tolterodine
    Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 5500 0.001
    0.02
    0.750
    15.0
    200 Fexofenadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 2000 8.00 1000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    201 Fexofenadine +
    Pseudoephedrine
    Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1500
    202 Fexofenedine +
    Pseudoephedrine (Sensitive)
    Antihistamine Human Plasma K3EDTA LC/MS/MS Premier XE 1.00
    2.00
    500
    1000
    203 Fingolimod Multiple sclerosis Human Blood K2EDTA LC/MS/MS API 5500 0.010 5.00
    204 Flecainide Anti–arrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 800
    205 Fluconazole Antifungal Human Plasma CPDA, EDTA LC/MS/MS API 2000 50 10000
    206 Flucytosine Antimycotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30
    207 Flucytosine Antifungal Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
    208 Fluoxetine +
    Norfluoxetine
    Antidepressant Human Plasma EDTA LC/MS/MS API 4000 2.00 400
    209 Fulvestrant Antineoplastic Human Plasma K3EDTA LC/MS/MS API3000 0.10 25
    210 Gabapentin Anticonvulsant Human Plasma EDTA LC/MS/MS API 2000 40.0 10000
    211 Gabapentin Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 40.0 6000
    212 Gefitinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 250
    213 Glibenclamide (Glyburide) Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
    214 Gliclazide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 5000
    215 Glimepiride Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
    216 Glimepiride Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 1.00 500
    217 Glipizide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2000
    218 Griseofulvin Antifungal Human Plasma K3EDTA LC/MS/MS API 2000 10.0 4000
    219 Granisetron Anti–emetic Human Plasma EDTA LC/MS/MS API 2000 0.15 15
    220 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS API 2000 43.77 5606
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    221 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 6000
    222 Hydralazine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 200
    223 Hydrochlorothiazide Diuretic Human Plasma EDTA LC/MS/MS API 2000 5.00 500
    224 Hydrochlorothiazide (Sensitive) Diuretic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
    225 Hydrochlorothiazine +
    Telmisartan
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.50
    5.00
    300
    1000
    226 Hydrocortisone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 4000 0.50 1000
    227 Hydroxycarbamide Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 100 30000
    228 Hydroxychloroquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 2000 2.00 600
    229 Hyoscine Butyl Bromide
    (Butyl Scopolamine)
    Abdominal pain Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.25
    230 Ibrutinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 100
    231 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 500 100000
    232 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 150 30000
    233 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 250 100000
    233 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 250 100000
    234 Imatinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API2000 25.0 8000
    235 Imatinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 2000 25.0 6000
    236 Indapamide Antihypertensive Human Blood K3EDTA LC/MS/MS API 4000 0.20 100
    237 Indomethacin Nonsteroidal anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 25.0 5000
    238 Indoramin Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.04 80
    239 Irbesaratan +
    Hydrochlorothiazide
    Antihypertensive
    Diuretic
    Human Plasma K3EDTA LC/MS/MS API 3000 10.0
    1.00
    5000
    500
    240 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 2000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    241 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 1000
    242 Itraconazole Antifungal Human Plasma CPDA, EDTA LC/MS/MS API 4000 2.00 600
    243 Itraconazole +
    Hydroxy Itraconazole
    Antifungal Human Plasma K3EDTA LC/MS/MS API 3000 2.00 600
    244 Ivabradine Heart rate lowering agent Human Plasma K3EDTA LC/MS/MS Premier XE 0.25 100
    245 Ivacaftor Cystic fibrosis Human Plasma K3EDTA LC/MS/MS API 3200 2.00 2000
    246 Ketoprofen Anti-Inflammatory,
    Analgesic
    Human Plasma K3EDTA LC/MS/MS API 3000 20.0 10000
    247 Lacosamide AED Human Plasma K3EDTA LC/MS/MS LCMS-8040 50.0 10000
    248 Lamivudine Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 60.0 6000
    249 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 40.0 10000
    250 Lamivudine +
    Tenofovir
    Antiviral Human Plasma K3EDTA LC/MS/MS API 3200 20.0
    5.00
    4000
    1000
    251 Lamivudine +
    Zidovudine
    Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 40.0
    60.0
    4000
    6000
    252 Lamivudine +
    Abacavir
    Antiviral Human Plasma EDTA LC/MS/MS API 3000 55.0
    30.0
    11000
    6000
    253 Lamuvudine +
    Neverapine +
    Zidovudine
    Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.0 6000
    254 Lamuvudine +
    Neverapine +
    Zidovudine
    Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 40.0
    50.0
    60.0
    4000
    5000
    6000
    255 Lansoprazole Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 5.00 2000
    256 Lansoprazole (Sensitive) Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 2.00 2000
    257 Lansoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
    258 Lapatinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 10.00 5000
    259 Lenalidomide Antineoplastic (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000
    260 Lenalidomide Antineoplastic (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 100
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    261 Letrozole Antineoplastic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 100
    262 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000
    263 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000
    264 Levocetirizine Non-sedative antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 10.0 600
    265 Levofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 16000
    266 Levothyroxine Thyroid Hormone Defficiency Human Plasma NA LC/MS/MS Premier XE 10.0 1000
    267 Linezolid Antibiotic Human Plasma K3EDTA LC/MS/MS API 3000 100 24000
    268 Lisinopril Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 1.00 200
    269 Lisinopril Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.50 60
    270 Lithium Antidepressant Human Plasma K3EDTA ICP OES Optima 8000 50.0 5000
    271 Lorcaserin Weight Loss Human Plasma K3EDTA LC/MS/MS API 4000 0.40 200
    272 Loperamide Antidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500 0.01 4.00
    273 Lopinavir +
    Ritonavir
    Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 30.0
    3.00
    15000
    1500
    274 Loratadine +
    Desloratadine
    Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 50
    275 Losartan Angiotensin II Receptor Antagonist Human Plasma K3EDTA LC/MS/MS API 3000 1.00 500
    276 Lumefantrine Antimalarial Human Plasma Na Heparin LC/MS/MS Premier XE 50.0 20000
    277 Lurasidone Antipsycotic Human Serum NA LC/MS/MS API4000 0.25 150
    278 Lurasidone Antipsycotic Human Plasma K3EDTA LC/MS/MS API 4000 0.25 150
    279 Mecitentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00 500
    280 Maraviroc Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 0.50 500
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    281 Meclizine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 300
    282 Mefenamic Acid (Sensitive) Non-steroidal Antiinflammatory Human Plasma K3EDTA LC/MS/MS API 2000 40.5 12000
    283 Mefenamic Acid (Sensitive) Non-steroidal Antiinflammatory Human Plasma K3EDTA LC/MS/MS API 3000 20.0 11000
    284 Mefenamic acid Non steroial anti inflammatory Human Plasma K3EDTA LC/MS/MS API2000 30.0 12000
    285 Memantine Anti-Alzheimer's Human Plasma EDTA LC/MS/MS API 3000 0.50 100
    286 Mercaptopurine Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 0.50 80.0
    287 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2000
    288 Metaxalone Muscle Relaxant Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000
    289 Metformin Antidiabetic Human Plasma EDTA HPLC HPLC-UV 40.0 7500
    290 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 40.0 7500
    291 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 7500
    292 Metformin +
    Sitagliptin
    Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 10.0
    2.00
    4000
    800
    293 Methimazole Antithyroid Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500
    294 Methotrexate antimetabolite and antifolate Human Plasma EDTA LC/MS/MS API 4000 1.00 250
    295 Methoxsalen Dermatological Human Plasma EDTA LC/MS/MS API 4000 1.00 200
    296 Methoxsalen (Sensitive) Dermatological Human Plasma EDTA LC/MS/MS API 4000 0.10 100
    297 Methyl Prednisolone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 3000 0.20 100
    298 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.30 300
    299 Metoprolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.30 300
    300 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.30 300
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    301 Metronidazole Antibacterial Human Plasma CPDA, EDTA HPLC HPLC-UV 100 40000
    302 Metronidazole Antibacterial Human Plasma K3EDTA LC/MS/MS Premier XE 100 40000
    303 Metronidazole Antibacterial Human Stool NA LC/MS/MS API-4000 0.50 250
    304 Minocycline Antibiotic Human Plasma Na Heparin LC/MS/MS API 4000 10.0 3000
    305 Minocycline Antibiotic Human Plasma K2EDTA LC/MS/MS API 4000 10.0 3000
    306 Mirabegron Urinary incontinence Human Plasma Na Heparin LC/MS/MS API 5500 0.100 80.0
    307 Mono Methyl Fumarate Multiple Sclerosis Human Plasma K3EDTA LC/MS/MS API 3000 10.0 5000
    308 Montalukast+
    Fexofenadin
    leukotriene receptor antagonist Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 2.0 1000
    309 Montalukast leukotriene receptor antagonist Human Plasma EDTA LC/MS/MS API 4000 5.0 1000
    310 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 5000
    311 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 40.0 10000
    312 Mycophenolic acid Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 300 50000
    313 Mycophenolic acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 40.5 20000
    314 Mycophenolate Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 40.5 20000
    315 Mycophenolate Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS Premier XE 200 50000
    316 Mycophenolate Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 40.0 20000
    317 Mycophenolate Mofetil Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 20.0 800
    318 Mycophenolate Mofetil Immunosuppressant Human Plasma EDTA LC/MS/MS API 4000 0.10 16.0
    319 Mycophenolate Mofetil Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 5500 0.01 10.0
    320 Nadolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 1.00 600
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    321 Naltrexone +
    6ß Naltrexone
    Opioid antagonist Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.10
    0.50
    35.0
    175
    322 Naproxen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 10.0 10000
    323 Naproxen Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 500 150000
    324 Naratriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
    325 Nateglinide Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 50.0 12000
    326 Nebivolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.05 5.00
    327 Nebivolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.04 15.0
    328 Nifedipine Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.40 200
    329 Nefopam Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 200
    330 Nevirapine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.00 5000
    331 Nilutamide Antiandrogen Human Plasma K3EDTA LC/MS/MS API 4000 40.00 8000
    332 Nilotinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 3000 6.00 3000
    333 Nitrofurantoin Antibiotic Human Plasma EDTA LC/MS/MS API 4000 10.0 1500
    334 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 2.0 600
    335 Norfloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000
    336 Nortriptyline Antidepressant Human Plasma EDTA LC/MS/MS API 3000 0.50 220
    337 Ofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000
    338 Olanzapine Antipsychotic Human Plasma EDTA LC/MS/MS API 3000 0.50 50.0
    339 Olmesartan Angiotensin II receptor
    antagonist
    Human Plasma K3EDTA LC/MS/MS API 4000 10.0 3000
    340 Olmesartan +
    Hydrochlorothiazide
    Angiotensin II receptor
    antagonist
    Diuretic
    Human Plasma K3EDTA LC/MS/MS API 4000 10.0
    1.00
    3000
    300
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    341 Olsalazine Ulcerative colitis Human Plasma K3EDTA LC/MS/MS API 4000 20.0 2000
    342 Omeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2000
    343 Omeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 2.00 2000
    344 Orphenadrine Antihistamine Human Plasma K3EDTA LC/MS/MS API 2000 4.00 800
    345 Oseltamivir +
    Oseltamivir Carboxylate
    Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 0.50
    2.00
    200
    800
    346 Oxaprozin Total NSAID Human Plasma K3EDTA LC/MS/MS LCMS-8040 500 160000
    347 Oxybutynin +
    Metabolite- N-Desethyl
    Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    0.50
    10.0
    100
    348 Oxybutynin +
    10, 11-Dihydro-10-hydroxy-
    Carbamazepine
    Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 20.0
    75.0
    4000
    15000
    349 Oxybutynin +
    Metabolite- N-Desethyl
    Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    0.50
    10.0
    100
    350 Paclitaxel (Total) Antineoplastic Human Plasma Na Heparin LC/MS/MS API 4000 5.00 15000
    351 Paclitaxel (Total) Antineoplastic Human Plasma Na Heparin LC/MS/MS API 4000 80.0 40000
    352 Paliperidone Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 150
    353 Paliperidone Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 50.0
    354 Paliperidone Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.050 50.0
    355 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 15.0 5000
    356 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 10.0 6000
    357 Paracetamol Antipyretic Human Plasma K3EDTA LC/MS/MS API 3000 200 20000
    358 Paroxetin Antidepressant Human Plasma K3EDTA LC/MS/MS API 3000 0.40 200
    359 Paroxetine Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.40 60.0
    360 Pemetrexed Lung Cancer Human Plasma K3EDTA LC/MS/MS API 3200 500 200000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    361 Perampanel Antiepileptic Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 1000
    362 Phenobarbital AEDs Human Plasma K3EDTA LC/MS/MS Premier XE 10.00 4000
    363 Pimozide Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.02 5.00
    364 Pindolol Beta Blocker Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
    365 Pioglitazone +
    Hydroxy Pioglitazone M IV
    Antihyperglycemic, antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 10.0
    5.00
    3000
    1500
    366 Piroxicam NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 10000
    367 Pomalidomide Antineoplastic (MultipleMyeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 150
    368 Posaconazole Antifungal Human Plasma K3EDTA LC/MS/MS API3000 2.00 2000
    369 Pramipexole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.00
    370 Pravastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.40 200
    371 Pravastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.30 200
    372 Praziquantal Anthelmintic Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000
    373 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 15000
    374 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 15000
    375 Pregabalin+
    Gabapentin+
    Carbamazepine+
    AEDs Human Plasma K2EDTA LC/MS/MS Premier XE 30.0
    100
    10.0
    6000
    20000
    2000
    376 Primaquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 0.50 200
    377 Primidone Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 50.00 40000
    378 Propafenone+
    5-Hydroxy Propafenone
    Antiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    0.20
    400
    400
    379 Pottasium Hypokalaemia Human Urine NA ICP OES Optima 8000 20000 3000000
    380 Prasugrel Metabolite R95913 Platelet Inhibitor (Prasugrel) Human Plasma K3EDTA LC/MS/MS API 4000 0.50 100
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    381 Prochlorperazine Tranquilliser Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.600
    382 Proguanil Antimalarial Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
    383 Promethazine Antihistaminic Human Plasma K3EDTA LC/MS/MS API2000 0.20 60
    384 Propofol Sedative-hypnotic Human Plasma K3EDTA LC/MS/MS API 5500 5.00 5000
    385 Propafenone +
    5-Hydroxy metabolite
    Anti-arrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE 5.00
    2.50
    1000
    500
    386 Propranolol +
    4-Hydroxy Propranolol(Free)
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 0.10
    0.30
    100
    30.0
    387 Pyrazinamide Antitubercular Human Plasma Na Heparin LC/MS/MS LCMS-8050 200 60000
    388 Quetiapine Antipsychotic Human Plasma EDTA LC/MS/MS Premier XE 2.00 2000
    389 Quetiapine Antipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 200
    390 Quinine Antimalarial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 8000
    391 Rabeprazole Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 2000 3.00 2000
    392 Rabeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 3.00 1000
    393 Raltegravir Antiretroviral Human Plasma K3EDTA LC/MS/MS API 4000 20.0 10000
    394 Ramipril Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 0.20 100
    395 Ramipril+
    Ramiprilat
    Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
    396 Ranitidine Antihistamine Human Plasma EDTA LC/MS/MS API 2000 5.00 1000
    397 Ranolazine Antianginal Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 8000
    398 Rasagiline Parkinsons disease plasma K3EDTA LC/MS/MS Waters 0.02 10.0
    399 Repaglinide Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 0.50 200
    400 Rifixamine Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 0.025 10.0
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    401 Rilpivirin Non-nucleoside Reverse
    Transcriptase Inhibitor
    Human Plasma K3EDTA LC/MS/MS API 2000 2.00 500
    402 Risperidone +
    9-Hydroxy Risperidone
    Antipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.20
    100
    100
    403 Ritonavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 2.50 1500
    404 Rivoroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 800
    405 Rivoroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 500
    406 Alzheimer's&Parkinson's
    Disease
    Alzheimer's&Parkinson's
    Disease
    Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 50.0
    407 Rizatriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 100
    408 Rizatriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 60.0
    409 Roflumilast +
    Roflumilast N-Oxide
    Severe COPD associated with chronic bronchitis Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.25
    40.0
    50.0
    410 Ropinirole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.0
    411 Ropinirole Antiparkinsonian Human Plasma K3EDTA LC/MS/MS API 4000 0.02 4.0
    412 Rosiglitazone +
    Metformin
    Antidiabetic Human Plasma EDTA LC/MS/MS API 2000 6.00
    40.0
    1100
    7600
    413 Rosiglitazone +
    N-Desmethyl Rosiglitazone
    Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 5.00
    2.50
    1000
    500
    414 Rosiglitazone Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS Premier XE 0.60 100
    415 Rosuvastatin Lowering Cholesterol Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150
    416 Rufinamide Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 30.0 9000
    417 S-Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 12.0
    418 S-Amlodipine+
    Hydrochlorothiazide
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03
    1.00
    12.0
    400
    419 S-Amlodipine+
    Hydrochlorothiazide
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03
    1.00
    12.0
    400
    420 Scopolamine Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.005 0.50
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    421 Sertraline Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 1.50 300
    422 Sertraline Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS API 3000 8.00 1040
    423 Sildenafil +
    Metabolite
    Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS API 3000 2.00 1000
    424 Simvastatin +
    β - hydroxy Acid
    Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.50 100
    425 Simvastatin +
    β - hydroxy Acid
    Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.25 32.0
    426 Simvastatin +
    Simvastatin acid
    Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.200
    0.200
    100
    100
    427 Simvastatin +
    Simvastatin acid
    Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    0.50
    200
    200
    428 Siimvastatin Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.040 20.0
    429 Simvastatin Acid Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.02 7.50
    430 Sirolimus Immunosuppressant Human Blood EDTA LC/MS/MS API 4000 0.40 40.0
    431 Sirolimus (Sensitive) Immunosuppressant Human Blood K3EDTA LC/MS/MS Premier XE 0.10 50.0
    432 Sitagliptin Antihyperglycemic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 800
    433 Sodium Phenyl Butyrate +
    Metabolite Phenyl acetate+
    Metabolite Phenylacetylglutamine
    For Urea cycle disorders Human Plasma K3EDTA LC/MS/MS API 2000 5 μg/mL
    1 μg/mL
    2 μg/mL
    750 μg/mL
    750μg/mL
    300 μg/mL
    434 Sofosbuvir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040 5.00 2000
    435 Sofosbuvir +
    Sofosbuvir GS331007
    Antiviral Human Plasma K3EDTA LC/MS/MS LC 8040 5.00
    10.0
    1500
    3000
    436 Solifenacin Urinary antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 125
    437 Solifenacin (Sensitive) Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 4000 0.20 130
    438 Sorafenib Antineoplastic Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 10000
    439 Sotalol Antiarrhythmic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 3000
    440 Sulfadiazine Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 250 40000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    441 Sumatripatan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
    442 Sunitinib Antineoplastic Human Plasma K3EDTA LC/MS/MS API 4000 0.25 100
    443 Tacrolimus Immunosuppressant Human Blood EDTA LC/MS/MS Premier XE 0.50 100
    444 Tacrolimus Immunosuppressant Human Blood EDTA LC/MS/MS Premier XE 0.25 75.0
    445 Tacrolimus Immunosuppressant Human Blood K3EDTA LC/MS/MS LCMS-8050 0.050 75.0
    446 Tadalafil Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 800
    447 Tamsulosin α1a-selective alpha blocker Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
    448 Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 3.00 1200
    449 Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 5.00 1000
    450 Telmisartan +
    Amlodipine
    Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 2.50
    0.075
    500
    15.0
    451 Temozolamide Antineoplastic Human Plasma K3EDTA LC/MS/MS Premier XE 100 20000
    452 Tenofovir Antiviral Human Serum NA LC/MS/MS API 4000 5.00 1000
    453 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000
    454 Tenofovir +
    Emtricitabine+
    Lamivudine
    Antiviral Human Plasma EDTA LC/MS/MS API 4000 4.00
    15.0
    20.0
    800
    3000
    4000
    455 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000
    456 Tenofovir+
    Emtricitabine
    Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 8.00
    30.0
    1600
    6000
    457 Tenofovir+
    Emtricitabine +
    Rilpivirine
    Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 4.00
    20.0
    1.00
    800
    4000
    4000
    458 Tenofovir+
    Emtricitabine +
    Nevirapine
    Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 4.00
    20.0
    1.00
    800
    4000
    4000
    459 Terbinafine Antifungal Human Plasma EDTA HPLC HPLC-UV 25.0 5000
    460 Terbinafine Antifungal Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 3000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    461 Teriflunomide Multiple sclerosis Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000
    462 Tetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.01 2.00
    463 Tetracycline Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 20.0 8000
    464 Tiagabine Anticonvulsant Human Plasma EDTA LC/MS/MS API 4000 0.50 250
    465 Ticagrelor Platelet aggregation inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 2.50 1200
    466 Tinidazole Antiprotozoal Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 30000
    467 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
    468 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.075 20.0
    469 Tolcapone +
    3-O-Methyltolcapone
    Reversible inhibitor of catechol- O-methyltransferase (COMT) Human Plasma K3EDTA LC/MS/MS API 4000 40.0
    2.00
    8000
    400
    470 Tolterodine Antimuscarinic Human Plasma EDTA LC/MS/MS API 3000 0.10 20.0
    471 Tolterodine +
    5-Hydroxy Methyl Tolterodine
    Antimuscarinic Human Plasma EDTA LC/MS/MS API 3000 0.03 10.0
    472 Topiramate Anticonvulsant Human Plasma CPDA, EDTA LC/MS/MS API 4000 18.0 5000
    473 Topiramate (Sensitive) Anticonvulsant Human Plasma EDTA LC/MS/MS API 4000 5.00 5000
    474 Topiramate Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 20.0 6000
    475 Total Iron Iron Defficiency Anaemia Human Serum NA ICP OES Optima 8000 500 60000
    476 Tramadol hydrochloride Analgesic Human Serum K3EDTA LC/MS/MS LCMS-8050 3.00 750
    477 Transferrin Bound Iron NA Human Serum NA ICP OES Optima 8000 200 8000
    478 Transferrin Bound Iron For Estimation of transferrin bound Iron after Ferrmoxytol and Ferric carboxy maltose therapy Dog Serum NA ICP OES Optima 8000 500 20000
    479 Tranylcypromine Antidepressant and Anxiolytic Human Plasma K3EDTA LC/MS/MS API 4000 0.30 150
    480 Trazodone Antidepressant Human Plasma EDTA LC/MS/MS API 4000 10.0 3000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    481 Trazodone Antidepressant Human Plasma EDTA LC/MS/MS API 3000 10.0 3000
    482 Trifluoperazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 8.00
    483 Trimetazidine Antianginal Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 202
    484 Trospium Urinary Antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
    485 Trospium (Sensitive) Urinary Antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.02 10.0
    486 Valacyclovir +
    Acyclovir
    Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 5.00
    50.0
    1000
    10000
    487 Valacyclovir +
    Acyclovir
    Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 5.00
    50.0
    1000
    10000
    488 Valacyclovir +
    Ganciclovir
    antiviral Human Plasma K3EDTA LC/MS/MS Premier XE 2.00
    20.0
    1000
    10000
    489 Valproic Acid Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 1000 150000
    490 Valproic Acid Anticonvulsant Human Plasma EDTA LC/MS/MS API 2000 1000 100000
    491 Valsartan Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 5.00 5000
    492 Valsartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 20.0 12000
    493 Valsartan +
    Hydrochlorothiazide
    Angiotension II Receptor
    Antagonist
    Diuretic
    Human Plasma K3EDTA LC/MS/MS API 4000 40.0.
    1.00
    12000
    300
    494 Venlafaxine +
    O - Desmethyl Venlafaxine
    Antidepressant Human Plasma EDTA LC/MS/MS API 4000 2.00
    3.00
    500
    750
    495 Venlafexine (Sensitive) +
    O - Desmethyl Venlafaxine
    Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.25
    0.50
    100
    200
    496 Vertaric acid Antihypertensive and Antioxidant Human Plasma K3EDTA LC/MS/MS API 4000 100.00 20000
    497 Vildagliptin Anti diabetic Human Plasma K3EDTA LC/MS/MS API2000 2.00 800
    498 Vidagliptin +
    Metformin
    Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 2.00
    10.0
    800
    4000
    499 Vilazodone Antidepressant Human Plasma K3EDTA LC/MS/MS API2000 0.30 60
    500 Voriconazole(Sensitive) Antifungal Human Plasma EDTA LC/MS/MS API 3000 30.00 9000
  • Validated Method List
    Sr. No. Drug Name Theraputic Class Matrix Anti- Coagulant Method Equipment LLOQ
    (ng/mL)
    ULOQ
    (ng/mL)
    501 Voriconazole(Sensitive) Antifungal Human Plasma K3EDTA LC/MS/MS API 3000 25.00 5000
    502 Vortioxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.05 20.0
    503 Zidovudine Antiviral Human Plasma EDTA HPLC HPLC-UV 75.00 6000
    504 Zidovudine (Sensitive) Antiviral Human Plasma Na Heparin HPLC HPLC-UV 20.00 4000
    505 Zinc (Zinc Acetate) Inhibit the absorption of copper in Wilson's disease Human Plasma K3EDTA ICP OES Optima 8000 300 25000
    506 Zolpidem Insomnia Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 300
    507 Zonisamide+
    Topiramate +
    Oxcarbazepine+
    Phenytoin
    Antiepileptic Human Plasma K2EDTA LC/MS/MS Premier XE 300
    100
    10.0
    60.0
    6000
    20000
    2000
    12000

Our exemplary regulatory track record

USFDA
33 times
Brazil ANVISA
7 times
WHO
5 times
UK MHRA
3 times
EU - AGES
1 times
South Africa - MCC
1 times
NPRA - Malaysia
4 times
DCGI
13 times